MedPath

Tissue factor pathway inhibitor (TFPI) in patients with lacunar stroke

Conditions
Stroke. Lacunar stroke. Cerebral small vessel disease
Registration Number
NL-OMON28742
Lead Sponsor
niversity Hospital Maastricht,PO Box 58006202 AZ MaastrichtThe Netherlands
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients:

1. First ever lacunar stroke patient (>18 years old)

Exclusion Criteria

Patients:

1. Use of oral anticoagulants, heparin (derivates) of substances with ulcerogenic action (adrenal gland hormones or anti-rheumatic medication).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evels of Tissue factor pathway inhibitor (TFPI) before and after administation of heparin in lacunar stroke patients and healthy controls.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath